概括
新的指南为激素受体阳性乳腺癌提供了优化的内分泌治疗策略. 这项专家共识涉及早期和转移性疾病,包括新型药物,如循环林依赖激酶4/6 (CDK4/6) 抑制剂,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 内分泌疗法是激素受体阳性乳腺癌 (HR+BC) 系统治疗的所有阶段的基石,从早期到转移性疾病.
- 最近内分泌药物和向疗法的进展,包括循环素依赖性激酶4/6 (CDK4/6) 抑制剂,已经显著改善了患者的治疗结果,并重新塑造了HR+BC的治疗环境.
- 随着临床研究数据的不断发展,需要不断优化治疗策略,以有效利用新的治疗选择.
研究的目的:
- 提出"关于乳腺癌内分泌治疗的专家共识 (2023年版) ",提供HR+BC管理的最新建议.
- 在新辅助,辅助和转移性环境中标准化临床诊断并优化HR+BC的治疗策略.
- 整合全球研究数据和临床经验,为医疗保健专业人员提供可操作的指南.
主要方法:
- 召集专家小组讨论乳腺癌内分泌治疗当前热门话题.
- 全球临床研究数据和已建立的临床实践经验的全面审查.
- 为HR+乳腺癌的内分泌治疗制定基于共识的建议.
主要成果:
- 该共识提供了关于使用内分泌疗法和CDK4/6抑制剂治疗HR+乳腺癌的最新指导.
- 建议涵盖跨新辅助,辅助和转移环境的治疗优化.
- 这些指南旨在标准化诊断方法和治疗干预措施.
结论:
- 2023年专家共识为优化HR+乳腺癌内分泌治疗提供了一个框架,整合了最近的进展.
- 遵守这些准则可以增强临床决策和改善患者在早期和晚期疾病的结果.
- 这种共识是临床医生管理HR+乳腺癌的重要资源.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Endocrine Signaling
64.4K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
64.4K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
What is the Endocrine System?
414.6K
The endocrine system sends hormones—chemical signals—through the bloodstream to target cells—the cells the hormones selectively affect. These signals are produced in endocrine cells, secreted into the extracellular fluid, and then diffuse into the blood. Eventually, they diffuse out of the blood and bind to target cells which have specialized receptors to recognize the hormones.
414.6K


